PMC:1852721 / 21764-22442 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/1852721","sourcedb":"PMC","sourceid":"1852721","source_url":"https://www.ncbi.nlm.nih.gov/pmc/1852721","text":"In general, usage has dictated the choice of the preferred designations for disorders. The preferred designations change over time, as popular usage changes; “mucoviscidosis” became “cystic fibrosis of the pancreas” and then simply “cystic fibrosis.” Usage (in the choice of particular eponyms, for example) tended to vary some between the United States and Europe, but this is now much less the case. The preferred designations in OMIM have increasingly been used as a standard in publications, along with the inclusion of OMIM entry numbers. All alternative designations of both phenotypes and genes, including historical ones, are usually listed in the heading of each entry.","tracks":[]}